person

Manuel G.

Country
Italy
Department
Ematologia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
13
Sites with multiple studies

Has run more than one trial at 13 of 79 partner sites.

Specializations

Lymphoma Management

The investigator specializes in treating various forms of Hodgkin's lymphoma, with particular expertise in managing both early-stage and advanced cases. Their research encompasses innovative therapeutic approaches for classical Hodgkin lymphoma, focusing on treatment optimization for different patient populations.

  • Early-stage Hodgkin lymphoma treatment
  • Advanced disease management strategies
  • Non-bulky disease approaches

Their work includes evaluation of metabolic tumor volume and PET-guided therapy decisions.

Refractory Disease Treatment

The investigator focuses on developing treatments for relapsed and refractory lymphomas, including specialized approaches for Primary Mediastinal Large B-cell Lymphoma. Their expertise extends to salvage therapy and innovative immunotherapy applications.

  • Immunotherapy integration
  • Salvage treatment protocols
  • Stem cell transplantation preparation

Their research includes novel combination therapies and response assessment using advanced criteria.

Virus-Associated Lymphomas

The investigator has developed expertise in treating Epstein-Barr Virus-positive lymphomas, exploring innovative therapeutic combinations. Their work includes investigation of targeted approaches for virus-associated malignancies.

  • EBV-positive lymphoma treatment
  • Novel drug combinations
  • Antiviral therapy integration

Their research encompasses evaluation of specialized therapeutic protocols for virus-driven lymphomas.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.